Espinoza Loyola Pamela Scarlett, Muratalla Bautista Diana Laura, Hernández Bautista Karen Adela, White Elizabeth Gil, González Moreno José Antonio, Torres Del Real Daniel Angel, Páez Zayas Víctor Manuel, Escorza-Molina Carla, Rodríguez Fernando Mondragón, Gómez Omar Vásquez, Fernández López Luis Jorge, Mogrovejo Vázquez Paul Santiago, Sánchez-Cedillo Isidoro Aczel, Visag Castillo Víctor Jose
Social Service Internship, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Department of Surgery Division of Transplantation Surgery, Hospital General de México, Mexico City 06720, Mexico.
ILIVER. 2024 Feb 6;3(1):100077. doi: 10.1016/j.iliver.2024.100077. eCollection 2024 Mar.
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world and is one of the leading indications for liver transplantation, liver transplantation is the gold standard treatment for end stage liver disease. Diagnosis is based up on radiological characteristics and rarely biopsy results. However treatment must be individualized to each patient to improve recurrences and outcomes. In this article, we focus on the different selection criteria for liver transplantation. This study aimed to investigate the distribution laws and research frontiers of international literature, so as to present holistic bibliometric evaluation of the studies on 5-year survival and disease-free recurrence in 5 years, according to hepatocarcinoma criteria for liver transplantation. The paper aims to review and analyze 5-year survival and disease-free recurrence based on hepatocarcinoma criteria for liver transplantation. It systematically examines and summarizes distribution characteristics and research frontiers through bibliometric analysis. A bibliographic search was implemented in PubMed/Medline, Clinical Key, Science Direct and Index Medicus with MESH terms, from the year 1996-2022. Patients selected for transplantation using the Metroticket 2.0 (MT2) criteria had the highest overall survival along with patients selected for transplantation using the Milan Criteria had the best 5-year disease-free recurrence. The Metroticket 2.0 criteria (MT2) and Milan Criteria (MC) have shown the most favorable post-transplant outcomes for patients with hepatocellular carcinoma (HCC). However, MC demonstrated the best 5-year disease-free recurrence rate, underscoring the significance of taking into account tumor morphology and biology when determining the eligibility of HCC patients for liver transplantation. The distribution characteristics and research frontiers by bibliometrics concerning prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma the collaborations are sufficient to reach a consensus that the Milan criteria are the best criteria.
肝细胞癌(HCC)是全球最常见的癌症之一,也是肝移植的主要适应证之一,肝移植是终末期肝病的金标准治疗方法。诊断基于影像学特征,很少依据活检结果。然而,治疗必须针对每个患者进行个体化,以改善复发情况和治疗效果。在本文中,我们聚焦于肝移植的不同选择标准。本研究旨在调查国际文献的分布规律和研究前沿,以便根据肝癌肝移植标准,对5年生存率和5年内无病复发的研究进行全面的文献计量学评价。本文旨在根据肝癌肝移植标准,对5年生存率和无病复发进行综述和分析。通过文献计量学分析,系统地考察和总结其分布特征和研究前沿。使用医学主题词(MESH)在PubMed/Medline、Clinical Key、Science Direct和Index Medicus中进行文献检索,检索时间跨度为1996年至2022年。采用梅洛蒂克2.0(MT2)标准选择进行移植的患者总体生存率最高,采用米兰标准选择进行移植的患者5年无病复发情况最佳。梅洛蒂克2.0标准(MT2)和米兰标准(MC)已显示出对肝细胞癌(HCC)患者最有利的移植后结果。然而,MC显示出最佳的5年无病复发率,这突出了在确定HCC患者肝移植资格时考虑肿瘤形态学和生物学特性的重要性。通过文献计量学分析肝细胞癌患者肝移植选择标准的预后作用的分布特征和研究前沿,各项研究足以达成共识,即米兰标准是最佳标准。